Related Experiment Video
Updated: Jul 4, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Atherosclerosis as a disease of failed endogenous repair
Andrey G Zenovich1, Doris A Taylor
1Center for Cardiovascular Repair, University of Minnesota, Minneapolis, MN 55455, USA.
Insights
Inflammation drives coronary artery disease (CAD). Stem/progenitor cells attempt vascular repair, but age and risk factors impair them, highlighting sex-based differences in CAD treatment strategies.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Immunology
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Inflammation is a key pathological mechanism in CAD progression, from endothelial dysfunction to heart failure.
- Atherosclerosis is increasingly recognized as a disease involving impaired endogenous vascular repair processes.
Purpose of the Study:
- To explore the role of stem/progenitor cells in vascular repair within the context of CAD.
- To investigate how aging and cardiovascular risk factors affect progenitor cell function.
- To examine sex-based differences in progenitor cell capacity and their implications for CAD pathogenesis and treatment.
Main Methods:
- Review of recent advances in stem/progenitor cell biology and their application in CAD.
- Identification of key progenitor cell populations involved in vascular repair (e.g., endothelial progenitor cells [AC133+/CD34+], vascular progenitors [CD31+/CD45(low)], KDR+ cells).
- Analysis of factors influencing progenitor cell efficacy, including age, risk factors, and sex.
Main Results:
- Stem/progenitor cells are mobilized for vascular repair in CAD.
- Age and cardiovascular risk factors significantly impair progenitor cell function, even before clinical CAD diagnosis.
- Emerging evidence suggests sex-based differences in progenitor cell repair capacity may explain clinical CAD disparities between men and women.
Conclusions:
- Enhancing endogenous vascular repair mechanisms by stem/progenitor cells offers a potential therapeutic avenue for CAD.
- Understanding the impact of age, risk factors, and sex on progenitor cells is crucial for developing effective, personalized CAD treatments.
- Quantifying cellular injury and repair processes is key to shifting the balance towards repair and preventing CAD progression.
Abstract:
As coronary artery disease (CAD) continues to be the primary cause of mortality, a more in-depth understanding of pathophysiology and novel treatments are being sought. The past two decades have established inflammation as a driving force behind CAD--from endothelial dysfunction to heart failure. Recent advances in stem/progenitor cell biology have led to initial applications of progenitor cells in CAD continuum and have revealed that atherosclerosis is, at least in part, a disease of failed endogenous vascular repair. Several key progenitor cell populations including endothelial progenitor cells (AC133+/CD34+ population), vascular progenitors (CD31+/CD45(low) population), KDR+ cells and other bone marrow subtypes are mobilized for vascular repair. However, age and risk factors negatively impact these cells even prior to clinical CAD. Sex-based differences in progenitor cell capacity for repair have emerged as a new research focus that may offer mechanistic insights into clinical CAD discrepancies between men and women. Quantifying injury and cell-based repair and better defining their interactions should enable us to halt or even prevent CAD by enhancing the repair side of the repair/injury equation.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

